Firms: Allens (Healthscope Limited); Gilbert + Tobin (Crescent Capital Partners)
Deal: Healthscope Limited’s sale of its Australian pathology operations to Crescent Capital Partners.
Value: $105 million
Key players: The Allens team was led by partner-elect Emin Altiparmak (pictured), with support from partner and co-head of the firm’s private equity practice, Mark Malinas. The team also comprised partners and lawyers from the firm’s Melbourne, Sydney and Brisbane offices.
Gilbert + Tobin partners advised Crescent.
Deal significance: Healthscope’s Australian pathology operations consist of about 550 collection centres and 31 pathology laboratories in Victoria, South Australia, New South Wales and the Northern Territory.
The sale will also see Healthscope transfer six skin clinics to Crescent.
The deal was announced to the market on 23 June 2015 and is expected to be completed next month.
Mr Malinas said this deal was part of a continuing trend that has seen heavy private equity interest in the Australian healthcare sector.
“We have seen significant deals in this sector involving private equity, in particular in the area of retirement homes and hospitals. This deal indicates that private equity appetite for Australian healthcare assets is still there.”